Inspire Medical Systems, Inc.
Inspire Medical Systems Reports Strong Q4 2024 Financial Results
Summary
Inspire Medical Systems, Inc. announced significant financial growth for the quarter and full year ended December 31, 2024. The company reported a 25% year-over-year revenue increase for Q4 2024 to $239.7 million, with a 28% increase for the full year 2024 to $802.8 million. Net income for Q4 2024 was $35.2 million, showing a strong increase from $14.8 million in the same period of 2023. The company also saw a 135% increase in diluted net income per share for Q4 2024 to $1.15. Inspire Medical Systems updated its 2025 outlook, anticipating revenue growth of 17% to 19% over 2024, with diluted net income per share guidance set between $2.10 and $2.20. The company's financial strength is further evidenced by its operating cash flow, which reached $130.2 million for the full year 2024.
Profitelligence Alerts
Get alerts for INSP
Be first to know when Inspire Medical Systems, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neurostimulation device that provides a unique and effective solution for patients who are unable to utilize traditional continuous positive airway pressure (CPAP) devices. Inspire Medical Systems significantly impacts the healthcare sector by offering a less invasive, patient-friendly alternative to surgical treatments for OSA, improving quality of life for those affected by sleep disorders. Headquartered in Minnesota, Inspire Medical Systems continues to expand its presence within the medical device market, collaborating closely with hospitals and medical professionals to enhance sleep health management globally. This company's contributions underscore a growing focus on personalized and technologically advanced approaches to medical challenges, marking its importance in the evolving landscape of healthcare solutions.
Official SEC Documents
Advertisement